DSpace logo

Search


Current filters:




Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 11 (Search time: 0.002 seconds).
Item hits:
Issue DateTitleAuthor(s)
2023-02Design, Synthesis, and Pharmacological Evaluation of Embelin–Aryl/alkyl Amine Hybrids as Orally Bioavailable Blood–Brain Barrier Permeable Multitargeted Agents with Therapeutic Potential in Alzheimer’s Disease: Discovery of SB-1448Jadhav, Hemant R.
2023-07Nutraceuticals and network pharmacology approach for acute kidney injury: A review from the drug discovery aspectJadhav, Hemant R.; Gaikwad, Anil Bhanudas
2023-07Identification of Azelastine and Carvedilol as Cholinesterase Inhibitors via Structure-Based Virtual Screening of FDA-approved DrugsJadhav, Hemant R.
2023Recent trends and spotlight on nucleotide-based drugs: novel targets, their design, delivery, and clinical potentialJadhav, Hemant R.
2023-08Progress in discovery and development of natural inhibitors of histone deacetylases (HDACs) as anti-cancer agentsJadhav, Hemant R.
2023Methoxy-naphthyl-Linked N-Benzyl Pyridinium Styryls as Dual Cholinesterase Inhibitors: Design, Synthesis, Biological Evaluation, and Structure–Activity RelationshipJadhav, Hemant R.
2023-10Discovery of blood-brain barrier permeable and orally bioavailable caffeine-based amide derivatives as acetylcholinesterase inhibitorsJadhav, Hemant R.
2023-11Targeting the epigenetic reader “BET” as a therapeutic strategy for cancerJadhav, Hemant R.
2023-11FDA approved fused-pyrimidines as potential PI3K inhibitors: a computational repurposing approachJadhav, Hemant R.
2023-10A Comprehensive Review of Systemic Targeted Therapies in Cancer TreatmentJadhav, Hemant R.